Antiretrovirals: beware when interrupting treatment

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1279, 2001-01, pp. : 2-2

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Interrupting drug treatment before surgery: risky business

By  

Inpharma, Vol. 1, Iss. 1257, 2000-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Initiating antiretrovirals during tuberculosis treatment: a drug safety review

By Gengiah Tanuja N   Gray Andrew L   Naidoo Kogieleum   Karim Quarraisha Abdool  

Expert Opinion on Drug Safety, Vol. 10, Iss. 4, 2011-07 ,pp. : 559-574

Informa Healthcare

Access to resources Recommend Favorite

Interrupting Drug Therapy in the Perioperative Period

By Noble D.W.  

Drug Safety, Vol. 25, Iss. 7, 2002-01 ,pp. : 489-495

Adis International

Access to resources Recommend Favorite

The safety of lumiracoxib when used in the treatment of arthritis

By Doggrell Sheila A  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 2, 2005-02 ,pp. : 347-350

Informa Healthcare

Access to resources Recommend Favorite

Treatment of chronic myeloid leukemia when imatinib fails

By Hehlmann Rüdiger   Jung-Munkwitz Susanne   Saußele Susanne  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 2, 2011-02 ,pp. : 269-283

Informa Healthcare

Access to resources Recommend Favorite